Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering
November 15th, 2019
Tag: Corporate/Financial News
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering
November 13th, 2019
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors
November 8th, 2019
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split
October 31st, 2019
Applied DNA Receives Extension from Nasdaq
October 3rd, 2019
APDN Reports FY’19 Q3 Results
August 13th, 2019
Applied DNA Reports Fiscal Third Quarter 2019 Financial Results
August 13th, 2019
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8th, 2019
Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET
August 6th, 2019